22nd Aug 2025 12:52
Hikma Pharmaceuticals PLC - London-based drugmaker with operations in Jordan and US - Non-Executive Director Laura Balan buys 3,500 shares at 1,820.70 pence each, worth GBP63,726, on Friday.
Current stock price: 1,834.49p, up 0.7% in London on Friday afternoon
12-month change: down 9.2%
By Michael Hennessey, Alliance News reporter
Comments and questions to [email protected]
Copyright 2025 Alliance News Ltd. All Rights Reserved.
Related Shares:
Hikma Pharmaceuticals